triluminate trial: deep dive into the outcomes #acc23 #wccardio
Published 1 year ago • 1K plays • Length 10:40Download video MP4
Download video MP3
Similar videos
-
10:48
triluminate trial: how these data impact my practice #acc23 #wccardio
-
4:30
triluminate: qol after transcatheter tricuspid-valve repair vs. medical therapy in severe tr
-
1:27:50
reshaping the transcatheter treatment of mitral and tricuspid regurgitation - pcr london valves 2024
-
12:45
triluminate trial: dr. paul sorajja discusses the findings with dr. emily cendrowski
-
4:33
pcr e-course 2020: one-year triluminate trial results — dr philipp lurz
-
6:04
percutaneous edge-to-edge repair for tricuspid regurgitation: 1-year outcomes from triluminate trial
-
4:27
triluminate trial shows “extremely favourable” results in patients with tricuspid regurgitation
-
7:19
tricuspid valve repair - triluminate clinical trial
-
33:19
echocardiographic approach to the tricuspid valve: 3-d echo 360 conference
-
11:20
echo assessment of tricuspid valve regurgitation
-
![[선천성 심장질환] 평생 관리 필요한 심장병, 가슴 아닌 '허벅지 혈관' 이용해 치료한다](https://i.ytimg.com/vi/XzIycBXplT4/mqdefault.jpg)
9:37
[선천성 심장질환] 평생 관리 필요한 심장병, 가슴 아닌 '허벅지 혈관' 이용해 치료한다
-
1:01:48
the triluminate pivotal trial: impact on practice and perspectives - webinar
-
59:59
a new focus on mitral and tricuspid valve disease - europcr 2022
-
11:51
t-teer for severe tr: 1-year outcomes from triluminate | jacc | tct 2024
-
15:43
cv grand rounds – secondary tricuspid regurgitation: the current state of affairs
-
1:32
triluminate: transcatheter repair of tricuspid regurgitation
-
12:00
triscend: 6-month outcomes of transfemoral tvr in patients with tricuspid regurgitation
-
1:33:46
a patient-focused transcatheter portfolio of options to treat tricuspid regurgitation - europcr 2022
-
58:52
pcr valves e-course: advancing mitral and tricuspid repair with the pascal repair system
-
4:13
ct coronary angiogram and pacemaker-lead related tricuspid valve regurgitation (leaflet anatomy)
-
4:40
transcatheter tricuspid valve repair: clasp tr study one-year results